← Leaderboards
Brian Thomas
Research Triangle Institute
$12,732,270
Attributed
$12,732,270
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.2M · FY2010–22$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$12,732,270 · 8
By mechanism
N01$12,731,632 · 7
N02$638 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Triangle Institute
Same institution · by research overlap
- Abhik Das$191,149,327
- Timothy R Fennell$4,803,434
- Bruce E Blough$9,425,198
- Susan J Sumner$42,620,690
- Katie Hayes$4,934,717
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsEquipment And Supply InventoriesNational Institute Of Drug AbuseContractsShipsSourceDosage FormsSiteContractorMaintenanceMedicalDrug AbusePerformancePreparationMarijuanaCigaretteNicotineExerciseNational Institute Of Neurological Disorders And StrokeDatabasesResearch PersonnelDrug Or ChemicalDrug AddictionInterest
Grant awards (23)
TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. POP AUGUST 4, 2019 - AUGUST 3, 2020.$696,418
N01 · FY2022 · DA · contact PI
IGF::OT::IGF : OPTION (NINDS)PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2019. N01DA-17-8934PURPOSE: TO EXERCISE OPTION PERIOD 01, QUANTITY$141,428
N01 · FY2021 · DA · contact PI
IGF::OT::IGF : OPTION (NINDS)PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2019. N01DA-17-8934PURPOSE: TO EXERCISE OPTION PERIOD 01, QUANTITY$186,992
N01 · FY2020 · DA · contact PI
IGF::OT::IGF : PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS. N01DA-15-7792. PERIOD OF PERFORMANCE 01/15/2015 - 01/14/2020.$753,868
N01 · FY2019 · DA · contact PI
TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. POP AUGUST 4, 2019 - AUGUST 3, 2020.$645,165
N01 · FY2019 · DA · contact PI
N01-DA-19-8952$643,533
N01 · FY2019 · DA · contact PI
IGF::OT::IGF : OPTION (NINDS)PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2019. N01DA-17-8934PURPOSE: TO EXERCISE OPTION PERIOD 01, QUANTITY$184,307
N01 · FY2019 · DA · contact PI
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD$1,066,860
N01 · FY2018 · DA · contact PI
IGF::OT::IGF : Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders. August 4, 2014 - August 3, 2019. N01DA-14-8918.$591,438
N01 · FY2018 · DA · contact PI
IGF::OT::IGF : OPTION (NINDS)PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2019. N01DA-17-8934PURPOSE: TO EXERCISE OPTION PERIOD 01, QUANTITY$523,276
N01 · FY2018 · DA · contact PI
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD$1,051,567
N01 · FY2017 · DA · contact PI
IGF::OT::IGF : Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders. August 4, 2014 - August 3, 2018. N01DA-14-8918.$678,958
N01 · FY2017 · DA · contact PI
IGF::OT::IGF : OPTION (NINDS)PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT. JULY 9, 2017 - JULY 8, 2018. N01DA-17-8934PURPOSE: TO EXERCISE QUANTITY OPTIONS 2(A) FIVE T$517,967
N01 · FY2017 · DA · contact PI
IGF::OT::IGF Administrative Cost - Contract Orientation & Kick Off Mtg, HHSN261201700013I, DTP-17-038, 08/01/17 - 09/30/17, Analysis of Anti-Cancer Chem & Pharm Formulations, PRB.$638
N02 · FY2017 · CA · contact PI
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD$1,074,978
N01 · FY2016 · DA · contact PI
IGF::OT::IGF : Purity Specifications, Storage and Distribution for Medications Development. July 9, 2012 - July 8, 2017. PURPOSE: To fix a typographical error in Modification 14.$528,250
N01 · FY2016 · DA · contact PI
IGF::OT::IGF PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS PERIOD OF PERFORMANCE 9/1/2015 - 2/29/2016: TASK ORDER 3 AWARD$887,600
N01 · FY2015 · DA · contact PI
Purity Specifications, Storage and Distribution for Medications Development$475,031
N01 · FY2015 · DA · contact PI
Purity Specifications, Storage and Distribution for Medications Development$524,626
N01 · FY2014 · DA · contact PI
Purity Specifications, Storage and Distribution for Medications Development$392,181
N01 · FY2013 · DA · contact PI
CONTRACT NO. HHSN271201200010C, NIDA REFERENCE NO. N01DA-12-8903 (RESEARCH TRIAN$424,781
N01 · FY2012 · DA · contact PI
PURITY SPECIFICATIONS, STORAGE AND DISTRIBUTION FOR MEDICATIONS DEVELOPMENT$371,204
N01 · FY2011 · DA · contact PI
Purity Specifications, Storage, & Distribution for MD$371,204
N01 · FY2010 · DA · contact PI